The effect of recombinant human growth hormone on responses to alloantigens in the pediatric transplant patient.
Recombinant human growth hormone (rhGH) improves growth in children after renal transplantation, but may be associated with augmented immune responses. We previously demonstrated that rhGH augments proliferative and cytotoxic responses and interferon-gamma (IFN-gamma) mRNA expression during a mixed leukocyte culture (MLC). In this study, we evaluated 12 pediatric patients after receiving a renal allograft from one of their parents. Peripheral blood mononuclear cells (PBMC) were isolated from patients and cultured with either donor or unrelated third-party PBMC in an MLC. Patients developed significant donor-specific hyporesponsiveness (DSH), however, no correlation was seen between the amount of DSH and graft function. Of the 12 patients, 2 developed augmented responses in the presence of rhGH. rhGH augments proliferation, cytotoxicity, and IFN-gamma expression during an MLC. Some patients develop increased responses to donor-specific alloantigens after renal transplantation. Further study is needed to better determine the significance of this finding.
Benfield
M R
MR
Department of Pediatrics, University of Alabama at Birmingham 35233, USA.
Vail
A
A
Waldo
F B
FB
Bucy
R P
RP
Kohaut
E C
EC
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D006085:Graft Survival / Q000276:immunology / Q000502:physiology; D013006:Growth Hormone / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D007519:Isoantigens / Q000276:immunology*; D007676:Kidney Failure, Chronic / Q000601:surgery; D016030:Kidney Transplantation / Q000276:immunology / Q000502:physiology*; D007959:Lymphocyte Culture Test, Mixed; D013602:T-Lymphocytes, Cytotoxic
D007519:Isoantigens; D013006:Growth Hormone